Quarterly Results

  • Company Name :
Glaxosmithkline Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500660
  • NSE Symbol:
  • GLAXO
  • P/E(TTM):
  • 39.69
  • ISIN Demat:
  • INE159A01016
  • Div & Yield%:
  • 2.32
  • EPS(TTM):
  • 58.74
  • Book Value(₹):
  • 100.52
  • Market Cap(₹Cr.):
  • 39,491.93
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 1,022.59 973.63 804.83
Excise Duty 0.00 0.00 0.00
Net Sales 1,022.59 973.63 804.83
Other Operating Income 0.00 0.00 0.00
Other Income 31.82 33.91 43.76
Total Income 1,054.41 1,007.54 848.59
Total Expenditure 655.01 638.95 554.08
PBIDT 399.40 368.59 294.51
Interest 1.19 0.51 0.42
PBDT 398.21 368.08 294.09
Depreciation 20.32 17.43 15.52
Tax 98.65 95.21 73.85
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 2.06 0.44 0.02
Reported Profit After Tax 277.18 255.00 204.70
Extra-ordinary Items 0.00 1.92 0.00
Adjusted Profit After Extra-ordinary item 277.18 253.08 204.70
EPS (Unit Curr.) 16.36 14.92 12.08
EPS (Adj) (Unit Curr.) 16.36 14.92 12.08
Calculated EPS (Unit Curr.) 16.36 15.05 12.08
Calculated EPS (Adj) (Unit Curr.) 16.36 15.05 12.08
Calculated EPS (Ann.) (Unit Curr.) 65.45 60.21 48.33
Calculated EPS (Adj) (Ann.) (Unit Curr.) 65.45 60.21 48.33
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 169.41 169.41 169.41
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 39.06 37.86 36.59
PBDTM(%) 38.94 37.80 36.54
PATM(%) 27.11 26.19 25.43